Patient Capital

Definition & Origins

Patient capital is capital deployed with no expectation of near-term returns, deliberately structured to give transformative businesses the time they need to realize their potential — without the distorting pressure of quarterly benchmarks, redemption risk, or imposed exit timelines. Where long-termism describes the disposition of the investor, patient capital describes the plumbing: the legal, structural and reputational arrangements that make the disposition possible.

In Anderson's hands the concept has three distinct layers. The first is the Scottish Mortgage investment trust itself — a closed-end vehicle whose capital cannot be redeemed by anxious holders, and whose board explicitly told shareholders to expect "no attempt... to mitigate short-term volatility." The second is Baillie Gifford's partnership structure, a private Scottish partnership that "thinks about our own business over decades not quarters." The third, developed from roughly 2010 onward, is the extension into private companies — pre-IPO investments in businesses like Grail, Ant Financial, and later SpaceX and ByteDance, where the absence of a quoted price removes the quarterly scoreboard altogether.

The intellectual origins are partly a critique of what public markets had become. The 2017 Annual Report states it bluntly: "we fear that equity markets are failing in their primary responsibility of encouraging and enabling future entrepreneurial success." Patient capital is Anderson's answer — an attempt to rebuild, inside a listed vehicle and later beyond it, the kind of capital that the early stock markets were created to provide: money that helps "create and nurture great companies."

Core Ideas

Structure determines behavior. No amount of stated long-term intent survives a structure that punishes it. Open-ended funds must sell into falling markets to meet redemptions; venture funds must return capital on fixed lives; quoted companies face a quarterly tribunal. Anderson's career was a sequence of structural escapes: the closed-end trust, the partnership-owned manager, and then private-market investments where "retaining private status allows companies to make decisions in a different way from those beholden to stock markets." As Tom Slater wrote in the 2016 report, the trust's two assets in winning private allocations were precisely structural: "our reputation as a long-term and supportive custodian" and a closed-end structure with "no liquidity constraints of open-ended funds or the limited life constraints of most venture capital structures."

Reputation is the access mechanism. Patient capital is not merely offered; it must be believed. Scottish Mortgage's decade-plus ownership of Amazon "stands out amidst short-termism elsewhere" and is the reason founders "are careful about whom they will allow onto their shareholder register" chose to let the trust in. Anderson made the logic explicit in Aberration or Premonition?: "We want companies to like to have us as shareholders. Ultimately we want Baillie Gifford being shareholders to be beneficial in itself."

The capital cost of building companies has collapsed — and markets missed it. A crucial economic observation from the 2016 report: cloud infrastructure ("pay a fee to Amazon Web Services") and mobile distribution ("three billion people") mean breakthrough businesses "can achieve huge scale whilst raising only modest amounts of capital," so founders "are staying private longer, avoiding the burdens of the public markets and being selective about their investors." Patient capital must therefore follow the companies upstream — into unlisted markets — or lose the opportunity set entirely.

Patient capital is active, not inert. It does not mean writing a check and disappearing. It means support at "particularly critical times": quiet work with Rolls-Royce's new management through corporate renewal, public defense of Tesla's right to invest through losses, and the willingness to absorb the reputational cost of standing with an unpopular company. "If we can prove in harsh times that we support teams trying to build great businesses and battling the forces of quarterly fund manager capitalism then these companies will hopefully be strengthened" (2017).

Practical Application

Pre-IPO and crossover investing. The trust participated in Grail's ~$1 billion private round (alongside Amazon and Tencent), took a large position in Ant Financial ("our largest single investment in a private company to date," 2019), and built a book of therapeutic healthcare companies — Unity, Intarcia, Denali — funded more substantively and earlier than the milestone-by-milestone venture convention, on the hypothesis that "more substantive funding... will extend time horizons and increase the chances of success" (2017).

Enduring the siege in public markets. Patient capital's harder test is public: Amazon through the 46% fall of 2006 and the Prime/AWS investment cycles; Tesla through "production hell" and near-bankruptcy; Illumina through years when the market saw only a sequencing box-maker. The 2016 review described the discipline in operational terms: "our position sizing reflected" the long timelines, and the trust added to Tesla when the Model 3 response revealed the probability shift.

Refusing to be the volatility conduit. A subtle but telling practice: the trust's managers worried that fair-value accounting for unlisted holdings "pushes us to become the conduit through which exaggerated stock market volatility is transmitted to unlisted companies," and resolved that their valuation process should emphasise "the evolving performance of these businesses" rather than "stock market noise" (2016). Patient capital protects portfolio companies even from the investor's own reporting machinery.

Letting companies choose their own clocks. In the 2022 interview Anderson noted that, unlike traditional venture capital, Scottish Mortgage did not press companies toward IPO: "if and when companies do go public and we're not pressing them to do so... we can usually buy more stock rather than look to have an avenue to sell out." The trust's horizon outlasts the exit event that terminates most investors' patience.

Common Misconceptions

Misconception 1: Patient capital is passive capital. The record shows the opposite — Grail's private round, Tesla top-ups, Rolls-Royce engagement, ARM defense. Patience defines the time structure; engagement defines the relationship. Anderson's phrase for the posture is "willing accomplices," not absentee landlords.

Misconception 2: It means ignoring price entirely. The 2017 report is explicit that unlisted valuations are watched for "undue pessimism or excessive euphoria," and the trust's own Tesla trim in 2021 shows price discipline at the extremes. Patient capital refuses quarterly judgment of price; it does not refuse judgment. The distinction is between reacting to the scoreboard and reassessing the game.

Misconception 3: It is a luxury only available to closed-end funds. Structure helps — decisively — but Anderson frames patience as also a choice available to any investor willing to look eccentric: decline the performance fee, decline the quarterly review, decline the redemption-driven sale. The institutional machinery matters because most investors will not make those choices; it is not a metaphysical prerequisite.

Anderson's Own Words

Thought Evolution

Key Letters / Related Concepts

Key letters: Scottish Mortgage Annual Report 2016 · Scottish Mortgage Annual Report 2017 · Scottish Mortgage Annual Report 2019 · Aberration or Premonition? (2018) · Masters in Business Interview (2022)

Related concepts: Long-Termism · Transformative Companies · Power Law of Returns · Benchmark Irrelevance · Refusal to Forecast

Source: Chian.io — James Anderson Knowledge Base